Orthopedic Devices - G20

  • G20
  • The projected revenue in the Orthopedic Devices market market in G20 is estimated to reach US$38.58bn in 2024.
  • This market is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 3.76%, leading to a market volume of US$46.40bn by 2029.
  • Among the in G20 countries, the United States is anticipated to generate the highest revenue, amounting to US$16,020.00m in 2024.
  • In the G20 country of Germany, there is a growing trend towards the adoption of advanced robotic-assisted orthopedic devices in the medical technology market.

Key regions: France, Netherlands, Europe, Germany, Japan

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Orthopedic Devices market in G20 countries is witnessing significant growth due to several key factors. Customer preferences for advanced and innovative orthopedic devices, increasing prevalence of orthopedic disorders, and rising geriatric population are driving the market growth. Additionally, favorable reimbursement policies, technological advancements, and increasing healthcare expenditure are further contributing to the expansion of the market. Customer preferences in the Orthopedic Devices market in G20 countries are shifting towards advanced and innovative products. Patients are increasingly seeking minimally invasive procedures and customized orthopedic devices that offer better outcomes and faster recovery. This has led to a surge in demand for implants and prosthetics that are designed to provide better functionality and improve the quality of life for patients. Trends in the market indicate a growing prevalence of orthopedic disorders, such as osteoarthritis, osteoporosis, and musculoskeletal injuries. These conditions are more common among the aging population, which is increasing in G20 countries. As the geriatric population continues to grow, the demand for orthopedic devices is expected to rise, as older individuals are more prone to orthopedic disorders and require joint replacements, spinal implants, and other orthopedic devices. Local special circumstances in the Orthopedic Devices market vary across G20 countries. For instance, in some countries, there may be a higher prevalence of sports-related injuries, leading to a greater demand for orthopedic devices such as braces and supports. In other countries, the focus may be more on joint replacement surgeries and implants due to a higher incidence of degenerative joint diseases. Additionally, the availability of healthcare infrastructure, regulatory policies, and cultural factors also influence the market dynamics in each country. Underlying macroeconomic factors, such as healthcare expenditure and reimbursement policies, play a crucial role in the growth of the Orthopedic Devices market in G20 countries. Countries with higher healthcare expenditure and favorable reimbursement policies tend to have a more developed market for orthopedic devices. Furthermore, technological advancements in the field of orthopedics, such as the use of 3D printing, robotics, and biocompatible materials, are also driving market growth by improving the precision and effectiveness of orthopedic procedures. In conclusion, the Orthopedic Devices market in G20 countries is experiencing significant growth due to customer preferences for advanced and innovative products, increasing prevalence of orthopedic disorders, and the rising geriatric population. Local special circumstances and underlying macroeconomic factors further contribute to the development of the market. With the continuous advancements in technology and increasing healthcare expenditure, the market is expected to expand further in the coming years.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)